CHRONIC STRESS AS A MODULATOR OF THE TUMOR IMMUNE MICROENVIRONMENT
Current evidence supports chronic stress as a potentially modifiab le component of tumor -immune interactions, but prospective mechanistic and interventional studies are required before stress - related parameters or adrenergic modulation can be used as validated predictive or therapeutic tools in oncology.